Subtopic Deep Dive
Nontuberculous mycobacteria identification
Research Guide
What is Nontuberculous mycobacteria identification?
Nontuberculous mycobacteria identification uses molecular methods like 16S rRNA and 23S rRNA gene sequencing alongside MALDI-TOF mass spectrometry to differentiate over 190 NTM species from clinical isolates.
NTM infections, excluding Mycobacterium tuberculosis, increasingly cause pulmonary disease worldwide, with species like Mycobacterium avium complex most common (Johnson and Odell, 2014, 414 citations). Accurate speciation relies on 16S rRNA sequencing validated against culture methods (Turenne et al., 2001, 306 citations). Guidelines emphasize diagnostics for therapy guidance (Daley et al., 2020, 791 citations).
Why It Matters
Precise NTM identification directs antibiotic selection for pulmonary infections, reducing treatment failures in cystic fibrosis patients (Floto et al., 2015, 457 citations). It distinguishes pathogenic from environmental strains, informing outbreak control as in M. chimaera surgical cases (Sax et al., 2015, 358 citations). Clinical guidelines integrate diagnostics with outcomes, improving survival in rising NTM-PD cases (Haworth et al., 2017, 769 citations; Ratnatunga et al., 2020, 447 citations).
Key Research Challenges
16S rRNA database accuracy
Incomplete or low-quality 16S rRNA databases misidentify NTM species, limiting resolution for closely related strains (Turenne et al., 2001). Validation against type strains remains essential. New species discovery exacerbates gaps.
MALDI-TOF spectrum variability
MALDI-TOF struggles with rare NTM due to inconsistent spectral profiles across instruments and growth conditions. Reference database expansion lags behind species descriptions. Culture requirements delay results (Johnson and Odell, 2014).
Genotype-clinical correlation
Linking NTM genotypes to disease outcomes hinders personalized therapy, as virulence varies by species and host (Ratnatunga et al., 2020). Guidelines note inconsistent associations. Multi-locus sequencing improves but lacks standardization.
Essential Papers
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange et al. · 2020 · European Respiratory Journal · 791 citations
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This gui...
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles Haworth, John Banks, Toby Capstick et al. · 2017 · Thorax · 769 citations
SeCTion 4: WhaT iS The evidenCe for TranSmiSSion of nTm BeTWeen individualS?recommendation ► Adequate infection control policies need to be implemented in both inpatient and outpatient settings to ...
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
Pedro E. A. da Silva, Juan Carlos Palomino · 2011 · Journal of Antimicrobial Chemotherapy · 527 citations
Tuberculosis (TB) remains one of the leading public health problems worldwide. Declared as a global emergency in 1993 by the WHO, its control is hampered by the emergence of multidrug resistance (M...
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
R. Andrés Floto, Kenneth N. Olivier, Lisa Saiman et al. · 2015 · Thorax · 457 citations
Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory lung disease such as...
The Rise of Non-Tuberculosis Mycobacterial Lung Disease
Champa N. Ratnatunga, Viviana P. Lutzky, Andreas Kupz et al. · 2020 · Frontiers in Immunology · 447 citations
The incidence and number of deaths from non-tuberculous mycobacterial (NTM) disease have been steadily increasing globally. These lesser known "cousins" of <i>Mycobacterium tuberculosis</i> (TB) we...
Nontuberculous mycobacterial pulmonary infections.
Margaret M. Johnson, John A. Odell · 2014 · PubMed · 414 citations
Pulmonary infections due to nontuberculous mycobacteria (NTM) are increasingly recognized worldwide. Although over 150 different species of NTM have been described, pulmonary infections are most co...
Prolonged Outbreak of Mycobacterium chimaera Infection After Open-Chest Heart Surgery
Hugo Sax, Guido V. Bloemberg, Barbara Hasse et al. · 2015 · Clinical Infectious Diseases · 358 citations
The epidemiological and microbiological features of this prolonged outbreak provided evidence for the airborne transmission of M. chimaera from contaminated heater-cooler unit water tanks to patien...
Reading Guide
Foundational Papers
Start with Turenne et al. (2001) for 16S rRNA database necessities; Johnson and Odell (2014) for NTM epidemiology and common species; da Silva and Palomino (2011) for resistance mechanisms applicable to NTM.
Recent Advances
Daley et al. (2020) for ATS/IDSA guidelines on diagnostics; Ratnatunga et al. (2020) for rising NTM lung disease trends; Sax et al. (2015) for outbreak genotyping examples.
Core Methods
16S/23S rRNA PCR-sequencing with BLAST; MALDI-TOF MS for intact cell profiling; multi-locus sequence typing for ambiguous cases.
How PapersFlow Helps You Research Nontuberculous mycobacteria identification
Discover & Search
Research Agent uses searchPapers('nontuberculous mycobacteria 16S rRNA MALDI-TOF') and citationGraph on Daley et al. (2020) to map 791-cited guideline impacts, then exaSearch for emerging species, and findSimilarPapers to uncover Turenne et al. (2001) database critiques.
Analyze & Verify
Analysis Agent applies readPaperContent on Johnson and Odell (2014) to extract species prevalence stats, verifyResponse with CoVe against Haworth et al. (2017) guideline claims, and runPythonAnalysis for phylogenetic tree clustering from 16S sequences with GRADE scoring for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in MALDI-TOF validation via contradiction flagging across Floto et al. (2015) and Sax et al. (2015), while Writing Agent uses latexEditText for assay protocol drafts, latexSyncCitations with 10 NTM papers, latexCompile for figures, and exportMermaid for diagnostic workflow diagrams.
Use Cases
"Analyze 16S rRNA sequences from my NTM isolates for species ID"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (BLAST alignment + phylogenetic tree with matplotlib) → outputs species probabilities and similarity scores.
"Draft LaTeX review on MALDI-TOF for NTM diagnostics"
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (spectra plots) → latexSyncCitations (Daley 2020 et al.) → latexCompile → PDF with embedded diagnostic flowchart.
"Find open-source code for NTM MALDI-TOF analysis pipelines"
Research Agent → paperExtractUrls (Johnson 2014) → Code Discovery → paperFindGithubRepo → githubRepoInspect → validated R script for spectrum matching.
Automated Workflows
Deep Research workflow scans 50+ NTM papers via searchPapers → citationGraph → structured report on 16S vs MALDI-TOF accuracy with GRADE grades. DeepScan applies 7-step CoVe to validate species prevalence claims from Ratnatunga et al. (2020) against guidelines. Theorizer generates hypotheses on resistance evolution from da Silva and Palomino (2011) applied to NTM.
Frequently Asked Questions
What defines nontuberculous mycobacteria identification?
NTM identification differentiates >190 species using 16S/23S rRNA sequencing and MALDI-TOF from M. tuberculosis via molecular and proteomic signatures (Turenne et al., 2001).
What are primary methods for NTM speciation?
16S rRNA gene sequencing provides genus-level ID with database validation; MALDI-TOF offers rapid species-level profiling after culture (Johnson and Odell, 2014).
What are key papers on NTM identification?
Turenne et al. (2001, 306 citations) stress 16S database quality; Daley et al. (2020, 791 citations) integrate diagnostics in guidelines; Johnson and Odell (2014, 414 citations) review pulmonary NTM.
What open problems exist in NTM identification?
Rare species misidentification persists due to database gaps; correlating genotypes with clinical virulence lacks standardization (Ratnatunga et al., 2020).
Research Mycobacterium research and diagnosis with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Nontuberculous mycobacteria identification with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.